Analyze Diet
Drug testing and analysis2022; 14(8); 1532-1538; doi: 10.1002/dta.3271

A quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.

Abstract: SR9009 and SR9011 are metabolic modulators pharmacologically targeting REV-ERB receptors as synthetic agonists. A liquid chromatography-tandem mass spectrometry method for the detection of SR9009 and SR9011 in equine plasma was developed and validated. Plasma samples were pretreated by protein precipitation with methanol and were loaded onto an ACQUITY ultra performance liquid chromatography high-strength silica C18 column (2.1 × 150 mm, 1.8 μm) for chromatographic separation. The mobile phase consisted of 5-mM ammonium formate (pH 3.0) in distilled water and 0.1% formic acid in acetonitrile, and a gradient elution was used at a flow rate of 0.25 ml/min. For the mass spectrometry detection, the selected reaction monitoring mode was used with transitions of 438.2 → 124.9 for SR9009, 479.2 → 125.1 for SR9011, and 292.2 → 109.1 for the internal standard (testosterone-d3) in the positive ionization mode. The linearity, lower limit of quantification, intra- and inter-day precision, accuracy, matrix effect, recovery, and stability were evaluated. The method was found to be accurate and reproducible for the quantitation of SR9009 and SR9011. The developed method was successfully applied to plasma samples of thoroughbreds injected intramuscularly with SR9009.
Publication Date: 2022-04-19 PubMed ID: 35396832DOI: 10.1002/dta.3271Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study revolves around the development and validation of a method for detecting the presence of metabolic modulators SR9009 and SR9011 in horse plasma. The method employs liquid chromatography and mass spectrometry, demonstrating both accuracy and reproducibility in its applications.

Research background and objective

  • SR9009 and SR9011 are metabolic modulators that function as synthetic agonists by pharmacologically targetting REV-ERB receptors.
  • The objective of this study was to devise a method for detecting these modulators in equine plasma, importantly for thoroughbreds, known for racing and performance events.

Methodology

  • The researchers used a method known as liquid chromatography-tandem mass spectrometry.
  • Plasma samples were pretreated by protein precipitation with methanol. They were then loaded onto an ACQUITY ultra-performance liquid chromatography high-strength silica C18 column for chromatographic separation.
  • The mobile phase consisted of 5-mM ammonium formate in distilled water and 0.1% formic acid in acetonitrile. A gradient elution was administered at a flow rate of 0.25 ml/min.

Mode of Detection

  • Mass spectrometry detection was utilized in this study, specifically the selected reaction monitoring mode.
  • The transitions were 438.2 → 124.9 for SR9009, 479.2 → 125.1 for SR9011, and 292.2 → 109.1 for the internal standard (testosterone-d3) during positive ionization mode.

Validation and Performance Evaluation

  • The criteria used for performance evaluation included linearity, the lower limit of quantification, intra- and inter-day precision, accuracy, matrix effect, recovery, and stability.
  • The method proved to be accurate and reproducible for the quantification of SR9009 and SR9011.

Practical Application

  • The developed method was effectively applied to plasma samples of thoroughbred horses injected intramuscularly with SR9009.
  • The ability to accurately detect the presence of SR9009 and SR9011 in equine plasma could potentially assist in ensuring fair play in equine sports by checking for unauthorised use of these performance modulators.

Cite This Article

APA
Kwak YB, Yu J, Yoo HH. (2022). A quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry. Drug Test Anal, 14(8), 1532-1538. https://doi.org/10.1002/dta.3271

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 14
Issue: 8
Pages: 1532-1538

Researcher Affiliations

Kwak, Young Beom
  • Korea Racing Authority, Gwachon, Republic of Korea.
  • Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.
Yu, Jundong
  • Korea Racing Authority, Gwachon, Republic of Korea.
Yoo, Hye Hyun
  • Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.

MeSH Terms

  • Animals
  • Chromatography, High Pressure Liquid / methods
  • Chromatography, Liquid
  • Horses
  • Pyrrolidines
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Tandem Mass Spectrometry / methods
  • Thiophenes

References

This article includes 13 references
  1. Dierickx P, Emmett MJ, Jiang C. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism.. Proc Natl Acad Sci U S A 2019;116(25):12147-12152.
    doi: 10.1073/pnas.1904226116google scholar: lookup
  2. Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet.. Jama 2017;318(20):2004-2010.
    doi: 10.1001/jama.2017.17069google scholar: lookup
  3. Geldof L, Deventer K, Roels K, Tudela E, Van Eenoo P. In vitro metabolic studies of REV-ERB agonists SR9009 and SR9011.. Int J Mol Sci 2016;17(10):1-16.
    doi: 10.3390/ijms17101676google scholar: lookup
  4. Thevis M, Schänzer W. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.. Rapid Commun Mass Spectrom 2016;30(5):635-651.
    doi: 10.1002/rcm.7470google scholar: lookup
  5. Mazzarino M, Rizzato N, Stacchini C, de la Torre X, Botrè F. A further insight into the metabolic profile of the nuclear receptor Rev-erb agonist, SR9009.. Drug Test Anal 2018;10(11-12):1670-1681.
    doi: 10.1002/dta.2538google scholar: lookup
  6. Jaiswal D, Ottwell R, Wildes DE, Douglas A, Vassar M. The Use of Superlatives in News Articles Covering Cardiovascular Drugs.. Eur Heart J Cardiovasc Pharmacother 2019;6(6):405-407.
    doi: 10.1093/ehjcvp/pvaa012google scholar: lookup
  7. Davies SR, Chan BKH, Moawad M, Garrett TR, Brooker L, Chakrabarty R. Production of certified reference materials for the sports doping control of the REV-ERB agonist SR9009.. Drug Test Anal 2019;11(2):257-266.
    doi: 10.1002/dta.2485google scholar: lookup
  8. Muscle Korea. https://www.sarmskorea.co.kr/. Accessed October 24, 2021.
  9. World Anti-Doping Agency. Standard prohibited list. https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf. Accessed November 12, 2021.
  10. Woldt E, Sebti Y, Solt LA. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.. Nat Med 2013;19(8):1039-1046.
    doi: 10.1038/nm.3213google scholar: lookup
  11. International Federation of Horseracing Authorities. Article 6 of the International Agreement on Breeding, Racing and Wagering. http://www.ifhaonline.org/resources/2018Agreement.pdf. Accessed November 12, 2021.
  12. Cutler C, White DL, Viljanto M. In vitro metabolism of the REV-ERB agonist SR-9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples.. Drug Test Anal 2021;14(1):3-8.
    doi: 10.1002/dta.3124google scholar: lookup
  13. Q2(R1) validation of analytical procedures: text and methodology guidance for industry. https://www.fda.gov/media/152208/download. Accessed November 12, 2021.

Citations

This article has been cited 1 times.
  1. Lu Z, Shen H, Li X, Li H, You W, Wang Z, Chen G. Circadian Rhythm Regulator REV-ERBα Attenuates Neuroapoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.. Neurochem Res 2023 Jun;48(6):1925-1944.
    doi: 10.1007/s11064-023-03872-5pubmed: 36757575google scholar: lookup